HealthQuill Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals, Inc. will acquire Sage Therapeutics, Inc.Ā for a total consideration of up to $795 million, to gain access to a medicine to treat postpartum depression.
Drugs Health Pharma

Supernus Pharma to acquire Sage Therapeutics for $795 million all cash

HQ Team June 22, 2025: Supernus Pharmaceuticals, Inc. will acquire Sage Therapeutics, Inc. for a total consideration of up to $795 million, as.

Read More
Supernus Pharmaceuticals Incā€™s injection for treating people with advanced Parkinsonā€™s disease got a green light from the US regulator after two earlier rejections.
Drugs Health Medical

Supernusā€™ injection to treat advanced Parkinsonā€™s gets US regulatorā€™s nod

Supernus Pharmaceuticals Incā€™s injection for treating people with advanced Parkinsonā€™s disease got a green light from the US regulator after two earlier rejections.

Read More